Evidence map›Paper›PMID 28027399›Full record

ArticleJournal of neurochemistry2017

Activation of brain-derived neurotrophic factor-tropomyosin receptor kinase B signaling in the pedunculopontine tegmental nucleus: a novel mechanism for the homeostatic regulation of rapid eye movement sleep.

Abigail K Barnes, Richa Koul-Tiwari, Jennifer M Garner, Phillip A Geist, Subimal Datta

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Deficiency of orexin signaling during sleep is involved in abnormal REM sleep architecture in narcolepsy.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Abigail K BarnesDepartment of Anesthesiology, Graduate School of Medicine, The University of Tennessee, Knoxville, Tennessee, USA.
Richa Koul-TiwariDepartment of Anesthesiology, Graduate School of Medicine, The University of Tennessee, Knoxville, Tennessee, USA.
Jennifer M GarnerDepartment of Anesthesiology, Graduate School of Medicine, The University of Tennessee, Knoxville, Tennessee, USA.
Phillip A GeistDepartment of Anesthesiology, Graduate School of Medicine, The University of Tennessee, Knoxville, Tennessee, USA.
Subimal DattaDepartment of Anesthesiology, Graduate School of Medicine, The University of Tennessee, Knoxville, Tennessee, USA.
University of Tennessee at Knoxville · USKnoxville College · US

Funding

CELLULAR AND NEUROCHEMICAL MECHANISMS OF REM SLEEPR01MH059839 · NIMH · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI DATTA, SUBIMAL · 1999 to 2017
$5.7M
NIMH NIH HHS R01 MH059839
6 · The paper itself

Abstract

Rapid eye movement (REM) sleep dysregulation is a symptom of many neuropsychiatric disorders, yet the mechanisms of REM sleep homeostatic regulation are not fully understood. We have shown that, after REM sleep deprivation, the pedunculopontine tegmental nucleus (PPT) plays a critical role in the generation of recovery REM sleep. In this study, we used multidisciplinary techniques to show a causal relationship between brain-derived neurotrophic factor (BDNF)-tropomyosin receptor kinase B (TrkB) signaling in the PPT and the development of REM sleep homeostatic drive. Rats were randomly assigned to conditions of unrestricted sleep or selective REM sleep deprivation (RSD) with PPT microinjections of vehicle control or a dose of a TrkB receptor inhibitor (2, 3, or 4 nmol K252a or 4 nmol ANA-12). On experimental days, rats received PPT microinjections and their sleep-wake physiological signals were recorded for 3 or 6 h, during which selective RSD was performed in the first 3 h. At the end of all 3 h recordings, rats were killed and the PPT was dissected out for BDNF quantification. Our results show that K252a and ANA-12 dose-dependently reduced the homeostatic responses to selective RSD. Specifically, TrkB receptor inhibition reduced REM sleep homeostatic drive and limited REM sleep rebound. There was also a dose-dependent suppression of PPT BDNF up-regulation, and regression analysis revealed a significant positive relationship between REM sleep homeostatic drive and the level of PPT BDNF expression. These data provide the first direct evidence that activation of BDNF-TrkB signaling in the PPT is a critical step for the development of REM sleep homeostatic drive.

Indexed as

AnimalsBrain-Derived Neurotrophic FactorCarbazolesDose-Response Relationship, DrugEnzyme InhibitorsHomeostasisIndole AlkaloidsMalePedunculopontine Tegmental NucleusRandom AllocationRatsRats, WistarReceptor, trkBSignal TransductionSleep, REMWakefulnessBrain-Derived Neurotrophic FactorCarbazolesEnzyme InhibitorsIndole AlkaloidsReceptor, trkBstaurosporine aglyconebrain-derived neurotrophic factorhomeostatic regulationpedunculopontine tegmental nucleusREM sleepsleep-wake activitytropomyosin receptor kinase B

Identifiers

PMID28027399
PMCPMC5364057
OpenAlexW2564630732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.